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Background: Although sevoflurane and propofol are commonly used anesthetics in rabbits, optimal doses of
remain unclear. We thus assessed the optimal hypnotic doses of sevoflurane and propofol, and evaluated the
influence of dexmedetomidine on sevoflurane and propofol requirements.
Methods: Twenty-eight Japanese white rabbits were randomly assigned to one of four groups (n = 7 each).
Rabbits were given either sevoflurane, propofol, sevoflurane + dexmedetomidine, or propofol + dexmedetomidine
(injected 30 μg∙kg−1∙hr−1 for 10 min followed by an infusion of 3.5 μg∙kg−1∙hr−1). Hypnotic level was evaluated with
Bispectral Index (BIS), a well-validated electroenchalographic measure, with values between 40 and 60 representing
optimal hypnosis. BIS measurements were made 10 minutes after the adjustment of target end-tidal sevoflurane
concentration in the sevoflurane group and sevoflurane + dexmedetomidine group, and at 10 min after the change
of infusion rate in the propofol group and propofol + dexmedetomidine group.
Results: BIS values were linearly related to sevoflurane concentration and propofol infusion rate, with or without
dexmedetomidine. Sevoflurane concentration at BIS = 50 was 3.9 ± 0.2% in the sevoflurane group and 2.6 ± 0.3% in
the sevoflurane + dexmedetomidine group. The propofol infusion rate to make BIS = 50 was 102 ± 5 mg∙kg−1∙hr−1
in the propofol group, and 90 ± 10 mg∙kg−1∙hr−1 in the propofol + dexmedetomidine group.
Conclusions: The optimal end-tidal concentration of sevoflurane alone was thus 3.9%, and optimal infusion rate for
propofol alone was 102 mg∙kg−1∙hr−1. Dexmedetomidine reduced sevoflurane requirement by 33% and propofol
requirement by 11%.
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Anesthesia is required for many animal experiments,
and often provided by sevoflurane or propofol. Those
agents are also used in anesthesia for rabbits [1]. Never-
theless, optimal anesthetic doses of sevoflurane and pro-
pofol in rabbits remain unclear. Dexmedetomidine, a
central alpha-2 receptor agonist, is sedative and also has
hypotensive, analgesic, and anesthetic sparing properties
[2]. The extent to which dexmedetomidine reduces the
need for sevoflurane and propofol in rabbits remains
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unless otherwise stated.The best-established monitor of hypnotic (anesthetic)
depth is the Bispectral Index (BIS) which is based on hu-
man electroencephalogram, but has also been used in
animals [3,4]. In this study we sought to clarify the BIS
monitoring usefulness in establishing the optimal doses
of sevoflurane or propofol in rabbits and also its useful-
ness in evaluating the influence of dexmedetomidine on
sevoflurane and propofol anesthetic requirements in rab-
bits. Therefore, our primary goal was to determine the
relationship between BIS and sevoflurane concentration
or propofol dose in rabbits. Our secondary goal was to
determine the optimal hypnotic doses of sevoflurane and
propofol, and the extent to which dexmedetomidine re-
duced anesthetic requirement.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Experiments were performed on 28 healthy Japanese
white rabbits weighing 2.8-3.9 kg. The Committee on
Animal Research, University of Yamanashi, Yamanashi,
Japan, approved this study. The acclimation period of
the rabbits was more than 3 weeks. The rabbits were
randomly assigned to one of four groups (sevoflurane,
propofol, sevoflurane and dexmedetomidine, and propo-
fol and dexmedetomidine; n = 7 in each group) based on
anesthetic methods. After obtaining intravenous access
in an ear vein, each rabbit was given either sevoflurane
5% in oxygen via mask or propofol 10 mg∙kg−1 iv
followed by an infusion of 50 mg∙kg−1∙hr−1. Rocuronium
5 mg∙kg−1 was injected simultaneously. Rocuronium was
injected intermittently as needed. Then the animals were
tracheostomized under local anesthesia with 1% lido-
caine and their lungs were mechanically ventilated with
an oxygen-air mixture. End-tidal CO2 was continuously
monitored (Vamos, Dräger medical, Tokyo, Japan), and
the tidal volume and respiratory rate were adjusted to
maintain arterial carbon dioxide tension between 35 and
45 mmHg. A femoral artery catheter was inserted to
monitor arterial blood pressure. Bicarbonated Ringer’s
solution was infused at 10 mL∙kg−1∙h−1. After completion
of tracheotomy, sevoflurane was decreased to 1% in the
sevoflurane anesthetized groups, and dexmedetomidine
was injected 30 μg∙kg−1∙hr−1 for 10 min (5 μg∙kg−1)
followed by an infusion of 3.5 μg∙kg−1∙hr−1 in the sevo-
flurane and dexmedetomidine group. In the propofol
group, infusion rate of propofol was continued at
50 mg∙kg−1∙hr−1. In the propofol and dexmedetomidine
group, infusion rate of propofol was decreased to
25 mg∙kg−1∙hr−1 and dexmedetomidine was injected
30 μg∙kg−1∙hr−1 for 10 min (5 μg∙kg−1) followed by an in-
fusion of 3.5 μg∙kg−1∙hr−1. Rectal (core) temperature was
maintained at 39 ± 0.5°C by a heating blanket. Arterial
blood pressure, heart rate and rectal temperature were
recorded using Dynascope DS-7101 L (Fukuda Denshi,
Tokyo, Japan).
The animals’ heads were shaved, and a four-electrode
pediatric BIS sensor was applied according to the previ-
ous method [3,5]. One electrode was placed 1 cm caudal
to the eye socket and others were placed on the head.
All electrode impedance levels were kept below 7.5 kΩ.
BIS values were obtained from an A-2000 monitor (Ver-
sion XP-3.12, Aspect Medical Systems, Norwood, MA,
USA). The BIS smoothing rate was set at 15 seconds.
BIS is a unitless value that ranges from 0 to 100, with
values between 40 and 60 indicating a suitable hypnotic
depth for surgery in humans [6].
After surgical procedures, 40 minutes were allowed for
stabilization. Then measurements of BIS and other
parameters such as arterial blood pressure, heart rate
and rectal temperature were started. In the sevofluranegroup, the inhaled concentration was progressively in-
creased by 0.2% at 10-minute intervals. In propofol and
propofol + dexmedetomidine groups, the propofol infu-
sion rate was progressively increased by 5 mg∙kg−1∙hr−1
at 10-minute intervals. In the sevoflurane + dexmedeto-
midine group, sevoflurane was initially inhaled at 1.0%
and was sequentially increased by 0.5%. BIS and other
parameters such as arterial blood pressure, heart rate
and rectal temperature were recorded 10 minutes after
each dose adjustment. At the end of the experiment,
each animal was killed by KCl infusion.
Systolic blood pressures, heart rates, and core temper-
atures were expressed as means ± standard deviations.
Those data were analyzed using analysis of variance
followed by a post hoc Tukey’s test. The BIS data was
assessed using logistic regression, and mean and 95%
confidence intervals (CI) were presented. Correlations
between each measurement were examined using a scat-
ter graph and linear regression. A P value less than 0.05
was considered statistically significant.
Results
In the sevoflurane group, systolic blood pressure pro-
gressively decreased as a function of sevoflurane concen-
tration (Table 1). In the sevoflurane + dexmedetomidine
group, systolic blood pressure and heart rate were
significantly lower than in the sevoflurane group (Table 1).
Blood pressure and heart rate were similarly decreased in
the propofol + dexmedetomidine group compared with
those in the propofol group (Table 2).
BIS values correlated with end-tidal sevoflurane con-
centrations in the sevoflurane group (BIS =83.8 - 8.7∙
[sevoflurane (%)], r = −0.677; Figure 1) and the sevoflur-
ane + dexmedetomidine group (BIS =67.2 - 6.6∙[sevoflur-
ane (%)], r = −0.662; Figure 2). The BIS value was also
highly correlated with propofol infusion rates in the pro-
pofol group (BIS = 95.2 - 0.44∙[Propofol (mg∙kg−1∙hr−1)],
r = −0.676; Figure 3) and the propofol + dexmedetomi-
dine group (BIS = 79.1 - 0.32∙[Propofol (mg∙kg−1∙hr−1)],
r = −0.558; Figure 4).
The sevoflurane concentration required to produce a BIS
value of 50 was 3.9 ± 0.2% (95% CI, 3.7-4.1%) in the sevo-
flurane group (Figure 1) and 2.6 ± 0.3% (95% CI, 2.3-2.9%)
in the sevoflurane + dexmedetomidine group (Figure 2).
The propofol infusion rate required to produce a BIS
value of 50 was 102 ± 5 mg∙kg−1∙hr−1 (95% CI, 97–
107 mg∙kg−1∙hr−1) in the propofol group (Figure 3) and
90 ± 10 mg∙kg−1∙hr−1 (95% CI, 80–100 mg∙kg−1∙hr−1) in
the propofol + dexmedetomidine group (Figure 4).
Discussion
Perhaps unsurprisingly, various species require different
anesthetic concentrations. However, the potency of vola-
tile anesthetics differs only slightly across species, with
Table 1 Systolic blood pressure, heart rate and body temperature in the sevoflurane and sevoflurane +
dexmedetomidine groups
Sevoflurane Sevoflurane + dexmedetomidine P
SBP (mmHg) S 1% 131 ± 24 93 ± 15 0.0036
SBP (mmHg) S 2% 112 ± 14 86 ± 16 0.0068
SBP (mmHg) S 3% 107 ± 19 84 ± 21 0.0343
SBP (mmHg) S 4% 107 ± 14 92 ± 16 NS
SBP (mmHg) S 5% 101 ± 7* 79 ± 12 0.0015
HR (bpm) S 1% 252 ± 43 222 ± 62 NS
HR (bpm) S 2% 258 ± 71 204 ± 36 0.0385
HR (bpm) S 3% 254 ± 59 227 ± 25 NS
HR (bpm) S 4% 239 ± 38 250 ± 32 NS
HR (bpm) S 5% 219 ± 5 267 ± 37 0.0058
BT (°C) S 1% 38.6 ± 0.8 38.5 ± 0.3 NS
BT (°C) S 2% 38.8 ± 1.0 38.6 ± 0.3 NS
BT (°C) S 3% 38.9 ± 1.2 38.7 ± 0.4 NS
BT (°C) S 4% 38.8 ± 0.1 39.0 ± 0.4 NS
BT (°C) S 5% 38.6 ± 0.4 38.5 ± 0.5 NS
SBP = systolic blood pressure, HR = heart rate, bpm= beats per minutes, BT = body temperature, S = sevoflurane concentration, NS not significant, *P <0.05 versus S 1%.
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phibian, rodents, and humans [7-9]. In contrast, require-
ments for intravenous anesthetics vary considerably. For
example, many laboratory animals such as rodents re-
quire opioid and ketamine doses an order-of-magnitude
greater than human patients [10,11].Table 2 Systolic blood pressure, heart rate and body tempera
groups
Propofol
SBP (mmHg) P 50 121 ± 14
SBP (mmHg) P 60 112 ± 13
SBP (mmHg) P 70 125 ± 11
SBP (mmHg) P 80 123 ± 8
SBP (mmHg) P 90 116 ± 7
SBP (mmHg) P 100 117 ± 9
HR (bpm) P 50 264 ± 29
HR (bpm) P 60 242 ± 34
HR (bpm) P 70 273 ± 19
HR (bpm) P 80 279 ± 24
HR (bpm) P 90 280 ± 21
HR (bpm) P 100 267 ± 21
BT (°C) P 50 39.1 ± 0.4
BT (°C) P 60 39.0 ± 0.5
BT (°C) P 70 38.9 ± 0.5
BT (°C) P 80 39.2 ± 0.4
BT (°C) P 90 39.1 ± 0.3
BT (°C) P 100 38.6 ± 0.6
SBP = systolic blood pressure, HR = heart rate, bpm=beats per minutes, BT = body temp
not significant.The classical measure of volatile anesthetic potency is
the Minimum Alveolar Concentration (MAC) which is
the partial pressure (or gas percentage) in the blood
which prevents 50% of subjects from moving in response
to a super-maximal painful stimulus such as a skin incision.
End-tidal concentrations represent alveolar concentrationture in the propofol and propofol + dexmedetomidine
Propopol + Dexmedetomidine P
107 ± 20 NS
105 ± 15 NS
108 ± 27 0.0473
111 ± 13 NS
102 ± 17 0.0344
95 ± 13 < 0.0001
215 ± 39 0.0064
192 ± 41 0.0019
208 ± 32 < 0.0001
206 ± 20 0.0001
221 ± 18 < 0.0001
218 ± 23 < 0.0001
39.2 ± 0.6 NS
39.1 ± 0.6 NS
39.2 ± 0.6 NS
39.3 ± 0.4 NS
39.2 ± 0.6 NS
39.3 ± 0.7 NS
erature, P = propofol, 50, 60, 70, 80, 90, 100 = 50, 60, 70, 80, 90, 100 mg∙kg−1∙hr−1, NS
Figure 1 Linear regression between bispectral index and
end-tidal sevoflurane concentration in rabbits anesthetized
with sevoflurane: BIS = 84 - 8.7∙[sevoflurane (%)], r = −0.68.
Figure 3 Linear regression between bispectral index and
propofol infusion rate in rabbits anesthetized with propofol:
BIS = 95 - 0.44∙[Propofol (mg∙kg−1∙hr−1)], r = −0.676.
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tidal concentrations thus represent effect-site concen-
trations. MAC is used to compare the potency of various
volatile anesthetics, as well as to evaluate the effects of
ancillary drugs [12], mutations [13], and ethnicity [14].
Although MAC is not defined for intravenous anesthetics,
it is possible to determine the plasma concentration that
prevents movement in 50% of human subjects [15].
While MAC is the oldest and best-established single
measure of volatile anesthetic effect, it is hardly the only
one. In fact, “anesthesia” is not a unitary function; in
addition to lack of movement, it incorporates amnesia,Figure 2 Linear regression between bispectral index and
end-tidal sevoflurane concentration in rabbits anesthetized
with sevoflurane and dexmedetomidine. Line represents linear
correlation: BIS = 67.2 - 6.6∙[sevoflurane (%)], r = −0.662.analgesia, and hemodynamic control. Various brain func-
tion monitors have thus been developed in an effort to
provide a more global measure of anesthetic (or at least
hypnotic) effect. Spectral edge frequency 95 (SEF95) was
the first generally accepted electroencephalographic
measure [16], but the BIS is now by far the most com-
monly used measure of hypnotic effect [17]. And unlike
many other measures, it appears to be generally reliable
across a variety of anesthetic drug classes and combina-
tions of anesthetic drugs including analgesics including
propofol, isoflurane, thiopental, or midazolam, supple-
mented with various amounts for opioids and nitrous
oxide [18].Figure 4 Linear regression between bispectral index and
propofol infusion rate in rabbits anesthetized with propofol
and dexmedetomidine: BIS = 79 - 0.32∙[Propofol (mg∙kg−1∙hr−1)],
r = −0.558.
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correlated with effect-site sevoflurane concentration [19],
and propofol blood concentration [20]. We found that BIS
values in rabbits were also linearly related to end-tidal
sevoflurane concentration and the propofol dose. The
correlation line slopes of sevoflurane and propofol were
similar to those observed in previous human studies
[19,20]. Comparable slopes suggest that BIS values are a
reasonable gauge of sedation depth in rabbits anesthe-
tized with sevoflurane or propofol.
The MAC of sevoflurane in rabbits is between 3.7 and
4.1% [21,22]. Interestingly, the end-tidal sevoflurane con-
centrations that produced BIS = 50 was almost identical
at 3.9%. This result is consistent with the general finding
that volatile anesthetic potency is comparable across a
wide variety of species.
The hypnotic dose of propofol in rabbits remains con-
troversial. Luo et al [23] used 24–48 mg∙kg−1∙hr−1 of pro-
pofol with ketamine and fentanyl. Baumgartner et al [24]
used 90–102 mg∙kg−1∙hr−1 of propofol with fentanyl or
dipyrone. Martín-Cancho et al [3] reported that propofol
dose of 36 mg∙kg−1∙hr−1 was associated with BIS values
of 69.1. From our results, dose of propofol that makes
BIS at 70 is calculated to be 57.3 mg∙kg−1∙hr−1 (Figure 3).
This dose is 1.6 times higher than that in the previous
study, however, the dose is not extremely high. Our
results may concur with the previous study. Results of
previous studies suggest that the necessary infusion rate
for propofol in rabbits varies from 24 to 100 mg∙kg−1∙hr−1
[23,24]. We found that infusion rate of propofol that
adjusted BIS value at 50 was 101 mg∙kg−1∙hr−1, suggesting
that the higher published doses may be most suitable. We
note, though, that dose must be interpreted in the context
of ancillary medications which themselves contribute to
anesthetic effect and thus influence BIS values. In patients,
a more typical dose would be 5.3 mg∙kg−1∙hr−1 [25]. Rab-
bits thus require more propofol than humans.
Dexmedetomidine decreases both the MAC of sevoflurane
and propofol requirements in humans [26,27]. For example,
dexmedetomidine decreases BIS in swine given a constant
infusion of propofol [28]. Dexmedetomidine similarly
decreases the MAC of sevoflurane by about 50% in
ponies [29]. Our results in rabbits are generally con-
sistent, with dexmedetomidine reducing sevoflurane
requirement by 33% and propofol requirement by 14%.
Continuous infusion rate of dexmedetomidine at 0.25-
1 μg∙kg−1∙hr−1 is recommended for humans. Kilic et al [30]
reported that the dose of dexmedetomidine was 10 μg ∙kg−1
followed by a maintenance dose of 10 μg∙kg−1∙hr−1. Chang
et al [31] reported that infusion dose of dexmedetomidine
was at 2 μg∙kg−1∙hr−1. Rabbits may need large amount of
dexmedetomidine compared with human. Used dose of
dexmedetomidine at 3.5 μg∙kg−1∙hr−1 in this study could be
adaptable for rabbits.Blood pressure and heart rate were essentially un-
changed by sevoflurane and propofol alone. Even at
100 mg∙kg−1 of propofol did not induce hypotension. In
contrast, dexmedetomidine decreased blood pressure
and heart rate just as would be expected from a central
alpha-2 receptor agonist that also acts on pre-synaptic
alpha-2 adrenergic receptor and suppresses norepin-
ephrine release [32,33]. The employed dose of dexme-
detomidine at 3.5 μg∙kg−1∙hr−1 could be the origin of
decrease in blood pressure. However, although propofol
100 mg∙kg−1∙hr−1 combined with dexmedetomidine 3.5
mcg∙kg−1∙hr−1 decreased blood pressure, that combin-
ation did not induce severe hypotension. In contrast to
our steady-state measurements, initiating dexmedeto-
midine — or rapid dose increases — can increase blood
pressure in response to unopposed stimulation of per-
ipheral alpha-2 receptors. However, the increase is usu-
ally transient and of minimal clinical consequence [34].
In animal studies, airway management is crucial. Su et
al [35] reported that tracheal intubation in rabbits was
difficult because of their features such as limited man-
dibular range, a large tongue and prominent incisors.
We also experienced that tracheal intubation in rabbits
was very difficult. Tracheotomy is commonly used
method for airway management for rabbit studies, and it
is a reliable method for protecting the airway. Therefore,
we employed tracheotomy.
A limitation of our study is that it depends critically
on BIS being valid in rabbits, and a BIS value of 50
representing optimal anesthetic depth. Although not
extensively validited, BIS appears to work well in animals
[4,5] including rabbits [3]. We also assumed that BIS
values have comparable meanings with sevoflurane, pro-
pofol, and dexmedetomodine. BIS is not a “universal
tool”. For example, nitrous oxide [36] and ketamine [37]
have little effects on BIS, although they are perfectly
good anesthetics. However, nitrous oxide and ketamine
appear to be exceptions, with most other anesthetics
having roughly comparable effects on BIS.
The rabbits in our study had a tracheostomy, but did
not experience the kind of pain that results from major
surgery. During major surgery, either sevoflurane or pro-
pofol would need to be accompanied by an analgesic,
usually an opioid [38,39]. And finally, we report propofol
dose rather than plasma concentration. Concentration
would provide a better pharmacokinetic estimate, and in
humans effect-site concentration would be calculated
from established models. But such models do not exist
for rabbits, and dose is more clinically useful than blood
concentration which cannot be measured in real time.
Conclusions
The sevoflurane concentration at BIS = 50 was 3.9% in
the sevoflurane group and 2.6% in the sevoflurane +
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make BIS = 50 was 101 mg∙kg−1∙hr−1 in the propofol
group, and 90 mg∙kg−1∙hr−1 in the propofol + dexmedeto-
midine group. The optimal end-tidal concentration of
sevoflurane alone was thus 3.9%, and optimal infusion
rate for propofol alone was 101 mg∙kg−1∙hr−1. Dexmede-
tomidine reduced sevoflurane requirement by 33% and
propofol requirement by 11%.
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